FDA Approved: CARVEDILOL — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for carvedilol submitted by Sandoz Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension
• Post-myocardial Infarction Left Ventricular Dysfunction

Drugs mentioned

• CARVEDILOL (Carvedilol)

Snippet

SUPPL AP for CARVEDILOL (CARVEDILOL)